Abstract:Schwann cell differentiation and myelination in the PNS are the result of fine-tuning of positive and negative transcriptional regulators. As myelination starts, negative regulators are downregulated, whereas positive ones are upregulated. Fully differentiated Schwann cells maintain an extraordinary plasticity and can transdifferentiate into "repair" Schwann cells after nerve injury. Reactivation of negative regulators of myelination is essential to generate repair Schwann cells. Negative regulators have also been implicated in demyelinating neuropathies, although their role in disease remains elusive. Here, we used a mouse model of Charcot-Marie-Tooth neuropathy type 1B (CMT1B), the P0S63del mouse characterized by ER stress and the activation of the unfolded protein response, to show that adult Schwann cells are in a partial differentiation state because they overexpress transcription factors that are normally expressed only before myelination. We provide evidence that two of these factors, Sox2 and Id2, act as negative regulators of myelination in vivo However, their sustained expression in neuropathy is protective because ablation of Sox2 or/and Id2 from S63del mice of both sexes results in worsening of the dysmyelinating phenotype. This is accompanied by increased levels of mutant P0 expression and exacerbation of ER stress, suggesting that limited differentiation may represent a novel adaptive mechanism through which Schwann cells counter the toxic effect of a mutant terminal differentiation protein.SIGNIFICANCE STATEMENT In many neuropathies, Schwann cells express high levels of early differentiation genes, but the significance of these altered expression remained unclear. Because many of these factors may act as negative regulators of myelination, it was suggested that their misexpression could contribute to dysmyelination. Here, we show that the transcription factors Sox2 and Id2 act as negative regulators of myelination in vivo, but that their sustained expression in Charcot-Marie-Tooth type 1B (CMT1B) represents an adaptive response activated by the Schwann cells to reduce mutant protein toxicity and prevent demyelination.

PAK2 is necessary for myelination in the peripheral nervous system

Control of OPC proliferation and repopulation by the intellectual disability gene PAK1 under homeostatic and demyelinating conditions

PMP2 regulates myelin thickening and ATP production during remyelination

Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression Through Polycomb Repressive Complex 2.

Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination

Abnormal Myelination in the Spinal Cord of PTPα-knockout Mice.

Myelination of peripheral nerves is controlled by PI4KB through regulation of Schwann cell Golgi function

Rab27a/Slp2-a Complex is Involved in Schwann Cell Myelination

Time-resolved function of cell polarity kinases PRKCZ and PRKCI in CNS myelination

Cathepsin D Deficiency Delays Central Nervous System Myelination by Inhibiting Proteolipid Protein Trafficking from Late Endosome/lysosome to Plasma Membrane

Rab27a/Slp2-a complex is involved in Schwann cell myelination.

PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination

Proteolipid Protein is Necessary in Peripheral As Well As Central Myelin.

PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior

A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication

EPAC Negatively Regulates Myelination via Controlling Proliferation of Oligodendrocyte Precursor Cells

Ninj2 regulates Schwann cells development by interfering laminin-integrin signaling

Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model

CNS myelination requires VAMP2/3-mediated membrane expansion in oligodendrocytes

Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy

Loss‐of‐Function of p21‐Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects